Lecture Notes in Education Psychology and Public Media

- The Open Access Proceedings Series for Conferences


Lecture Notes in Education Psychology and Public Media

Vol. 50, 26 April 2024


Open Access | Article

Analysis and Consideration of Legal Issues Related to Stem Cell Therapy

Lan Jiang * 1
1 Kaplan International College London

* Author to whom correspondence should be addressed.

Lecture Notes in Education Psychology and Public Media, Vol. 50, 220-224
Published 26 April 2024. © 2023 The Author(s). Published by EWA Publishing
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citation Lan Jiang. Analysis and Consideration of Legal Issues Related to Stem Cell Therapy. LNEP (2024) Vol. 50: 220-224. DOI: 10.54254/2753-7048/50/20240948.

Abstract

Stem cell therapy has gained momentum in recent years and has positively and innovatively impacted the biomedical field. This paper uses a comprehensive literature analysis and comparative methodology to compare the differences in the development and regulatory systems of stem cell therapies in the UK and China through the available references. The legal framework for stem cell therapies is more complete in the UK, and the government has invested in a regulatory system that promotes research and development. By contrast, China has had problems with surveillance confusion in the past. In recent years, it has worked to standardize the development of therapies and strengthen the regulatory system. While both countries are improving their censorship, some challenges remain. Based on the challenges analyzed, this paper intends to provide suggestions to those involved in stem cell therapies to develop better in the future.

Keywords

stem cell therapy, legal framework, regulatory

References

1. Hoang, D. M., Pham, P. T., Bach, T. Q., Ngo, A. T., Nguyen, Q. T., Phan, T. T., … Nguyen, L. T. (2022a). Stem cell-based therapy for human diseases. Signal Transduction and Targeted Therapy, 7(1). doi:10.1038/s41392-022-01134-4

2. El-Kadiry, A. E.-H., Rafei, M., & Shammaa, R. (2021). Cell therapy: Types, regulation, and clinical benefits. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.756029

3. Zarzeczny, A., Atkins, H., Illes, J., Kimmelman, J., Master, Z., Robillard, J. M., … Caulfield, T. (2018). The stem cell market and policy options: A call for clarity. Journal of Law and the Biosciences, 5(3), 743–758. doi:10.1093/jlb/lsy025

4. Bell, L., & Devaney, S. (2007). Gaps and overlaps: Improving the current regulation of stem cells in the UK. Journal of Medical Ethics, 33(11), 621–622. https://doi.org/10.1136/jme.2007.022657

5. UK parliament. (2013, March). POST Report March 2013 Stem Cell Research https://www.parliament.uk/globalassets/documents/post/17459-Houses-of-Parliament.pdf

6. Gao, J., & Gao, C. (2022). Development and regulation of stem cell‐based therapies in China. Cell Proliferation, 55(8). doi:10.1111/cpr.13217

7. Li, C. (2022). Strengthening regulations, recent advances and remaining barriers in stem cell clinical translation in China: 2015–2021 in review. Pharmacological Research, 182, 106304.

8. Lysaght, T., Kerridge, I. H., Sipp, D., Porter, G., & Capps, B. J. (2017). Ethical and regulatory challenges with autologous adult stem cells: a comparative review of international regulations. Journal of Bioethical Inquiry, 14, 261-273.

9. Blasimme, A., & Rial-Sebbag, E. (2013). Regulation of cell-based therapies in Europe: current challenges and emerging issues. Stem cells and development, 22(S1), 14-19.

10. Jiang, L. (2019). Regulation, patentability and morality of human embryonic stem cell in China: a comparative study of the US and Europe. Bangor University (United Kingdom).

11. Rees, V. (2020, April 20). Stem Cells in the clinic: How are they regulated?. European Pharmaceutical Review. https://www.europeanpharmaceuticalreview.com/article/117011/stem-cells-in-the-clinic-how-are-they-regulated/

Data Availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:

1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.

3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).

Volume Title
Proceedings of the 2nd International Conference on Social Psychology and Humanity Studies
ISBN (Print)
978-1-83558-397-5
ISBN (Online)
978-1-83558-398-2
Published Date
26 April 2024
Series
Lecture Notes in Education Psychology and Public Media
ISSN (Print)
2753-7048
ISSN (Online)
2753-7056
DOI
10.54254/2753-7048/50/20240948
Copyright
26 April 2024
Open Access
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Copyright © 2023 EWA Publishing. Unless Otherwise Stated